Cite
MLA Citation
Franck Morschhauser et al.. “Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.” Lancet, vol. 6, no. 8, 2019, pp. e429–e437. http://access.bl.uk/ark:/81055/vdc_100088832603.0x000006